Drug profile · INN
pantoprazole
APO-PANTOPRAZOLE
pantoprazole (APO-PANTOPRAZOLE) is a potassium-transporting atpase inhibitor. Associated with Alphapharm Pty Ltd.
Drug details — pantoprazole
- Class
- Alimentary tract and metabolism (A02)
- Route
- —
- Patents
- 4
- Programs
- 12
- Data quality
- 0.89
Quick answer
pantoprazole (APO-PANTOPRAZOLE) is a potassium-transporting atpase inhibitor. Associated with Alphapharm Pty Ltd.
Key facts
Mechanism of action
Potassium-transporting ATPase inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 8758817
Dosage form containing (S)-pantoprazole as active ingredient
granted -
US 8754108
Freeze-dried pantoprazole preparation and pantoprazole injection
granted -
US 8703192
Dosage form containing pantoprazole as active ingredient
granted -
US 7683177
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
granted
Frequently asked questions
What is pantoprazole?
pantoprazole (APO-PANTOPRAZOLE) is a potassium-transporting atpase inhibitor. Associated with Alphapharm Pty Ltd.
What is the brand name for pantoprazole?
APO-PANTOPRAZOLE is a marketed brand name for pantoprazole. Check FDA Drugs@FDA for the current US label holder and prescribing information.